palbociclib 125 MG Oral Capsule

RxCUI: 1601388
RxNorm name: palbociclib 125 MG Oral Capsule
Display name: palbociclib 125 MG Oral Capsule
Full name: palbociclib 125 MG Oral Capsule
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:24

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Ibrance	PALBOCICLIB	Pfizer Laboratories Div Pfizer Inc	e0e6412f-50b4-4fd4-9364-62818d121a07	2026-07-02	Warnings, Adverse reactions	Exact identifier rxcui: 1601388

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
e0e6412f-50b4-4fd4-9364-62818d121a07	palbociclib 125 MG Oral Capsule	SCD	21	These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE ® (palbociclib) capsules, for oral use Initial U.S. Approval: 2015	20260225
e0e6412f-50b4-4fd4-9364-62818d121a07	palbociclib 125 MG Oral Capsule	PSN	21	These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE ® (palbociclib) capsules, for oral use Initial U.S. Approval: 2015	20260225